Tag: Pharmaceutical Market Forecasting

Rare disease markets have an odd commercial paradox built into them: the patient population is tiny, but the market opportunity can still be substantial. That’s what makes forecasting them fundamentally different from forecasting a conventional primary care or high-prevalence therapy market. A forecast built mainly... Continue reading